For in vitro diagnostic use. Others Elecsys BRAHMS PCT IVD Elecsys® BRAHMS PCT CPS_000496 09318712190 PCT Brahms-Roche Elecsys cobas e100 V2.1 Elecsys BRAHMS PCT 07613336191811 Reagents, kits 100 tests cobas e 411/601/602 true 09318712200 PCT Brahms-Brahms Elecsys cobas e100V2.1 Elecsys BRAHMS PCT 07613336191804 Reagents, kits 100 tests cobas e 411/601/602 true 08828679200 PCT Brahms(Brahms) Elecsys E2G 300 V2 Elecsys BRAHMS PCT 07613336166666 Reagents, kits 300 tests cobas e 402/801 true 08828644200 PCT Brahms(Brahms) Elecsys cobas e100 V2 Elecsys BRAHMS PCT 07613336166659 Reagents, kits 100 tests cobas e 411/601/602 true 09318747200 PCT Brahms-Brahms Elecsys E2G 300 V2.1 Elecsys BRAHMS PCT 07613336191828 Reagents, kits 300 tests cobas e 402/801 true 09318747190 PCT Brahms-Roche Elecsys E2G 300 V2.1 Elecsys BRAHMS PCT 07613336191835 Reagents, kits 300 tests cobas e 402/801 true 08828644190 PCT Brahms (Roche) Elecsys cobas e100 V2 Elecsys BRAHMS PCT 07613336166635 Reagents, kits 100 tests cobas e 411/601/602 true 08828679190 PCT Brahms (Roche) Elecsys E2G 300 V2 Elecsys BRAHMS PCT 07613336166642 Reagents, kits 300 tests cobas e 402/801 true 09318712500 Elecsys BRAHMS PCT en 3 FF00000006DF990E FF00000004DA6C0E 09318712190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of procalcitonin (PCT) in human serum and plasma. PCT is a marker of host response to bacterial infection. The Elecsys BRAHMS PCT assay is indicated as an aid to be used in conjunction with clinical evaluation for:the early detection of clinically relevant bacterial infectionsthe assessment of the degree of severity and the prognosis of the outcome of systemic bacterial infection, sepsis, and septic shockidentifying patients that benefit from antibiotic treatmentmonitoring of antibiotic therapyassessing the success of antibiotic therapyin patients with suspected or confirmed bacterial infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09318712501 Elecsys BRAHMS PCT en 2 FF0000000501740E FF00000004DA060E 09318712200 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of procalcitonin (PCT) in human serum and plasma. PCT is a marker of host response to bacterial infection. The Elecsys BRAHMS PCT assay is indicated as an aid to be used in conjunction with clinical evaluation for:the early detection of clinically relevant bacterial infectionsthe assessment of the degree of severity and the prognosis of the outcome of systemic bacterial infection, sepsis, and septic shockidentifying patients that benefit from antibiotic treatmentmonitoring of antibiotic therapyassessing the success of antibiotic therapyin patients with suspected or confirmed bacterial infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08828679502 Elecsys BRAHMS PCT en 2 FF0000000476AF0E FF0000000476AF0E 08828679200 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma.The Elecsys BRAHMS PCT assay can be used to aid in the early detection of clinically relevant bacterial infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08828679502 Elecsys BRAHMS PCT en 1 FF0000000367BB0E FF0000000367BB0E 08828679200 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma.The Elecsys BRAHMS PCT assay can be used to aid in the early detection of clinically relevant bacterial infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en ms_08828644200 Elecsys BRAHMS PCT en 2 FF000000045CCD0E FF00000003AEC40E 08828644200 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma.The Elecsys BRAHMS PCT assay can be used to aid in the early detection of clinically relevant bacterial infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09318747501 Elecsys BRAHMS PCT en 1 FF00000004DAE10E FF00000004DAE10E 09318747200 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of procalcitonin (PCT) in human serum and plasma. PCT is a marker of host response to bacterial infection. The Elecsys BRAHMS PCT assay is indicated as an aid to be used in conjunction with clinical evaluation for:the early detection of clinically relevant bacterial infectionsthe assessment of the degree of severity and the prognosis of the outcome of systemic bacterial infection, sepsis, and septic shockidentifying patients that benefit from antibiotic treatmentmonitoring of antibiotic therapyassessing the success of antibiotic therapyin patients with suspected or confirmed bacterial infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09318747500 Elecsys BRAHMS PCT en 2 FF00000006DFA30E FF00000004DB030E 09318747190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of procalcitonin (PCT) in human serum and plasma. PCT is a marker of host response to bacterial infection. The Elecsys BRAHMS PCT assay is indicated as an aid to be used in conjunction with clinical evaluation for:the early detection of clinically relevant bacterial infectionsthe assessment of the degree of severity and the prognosis of the outcome of systemic bacterial infection, sepsis, and septic shockidentifying patients that benefit from antibiotic treatmentmonitoring of antibiotic therapyassessing the success of antibiotic therapyin patients with suspected or confirmed bacterial infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08828644500 Elecsys BRAHMS PCT en 3 FF00000006E0EC0E FF00000003AF4A0E 08828644190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma.The Elecsys BRAHMS PCT assay can be used to aid in the early detection of clinically relevant bacterial infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08828644501 Elecsys BRAHMS PCT en 2 FF00000005E1120E FF000000043C9C0E 08828644190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Indication for useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma (K2‑EDTA, K3‑EDTA and Li‑Heparin).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.Used in conjunction with other laboratory findings and clinical assessments, Elecsys BRAHMS PCT is intended for use as follows:to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock, to determine the change in PCT level over time as an aid in assessing the cumulative 28‑day risk of all-cause mortality for patients diagnosed with severe sepsis or septic shock in the ICU or when obtained in the emergency department or other medical wards prior to ICU admission,to aid in decision making on antibiotic therapy, for inpatients or patients in the emergency department with suspected or confirmed lower respiratory tract infections (LRTI) – defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of chronic obstructive pulmonary disease (AECOPD), to aid in decision making on antibiotic discontinuation for patients with suspected or confirmed sepsis. en 08828679501 Elecsys BRAHMS PCT en 4 FF00000006F5610E FF000000043C9E0E 08828679190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Indication for useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma (K2‑EDTA, K3‑EDTA and Li‑Heparin).The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers.Used in conjunction with other laboratory findings and clinical assessments, Elecsys BRAHMS PCT is intended for use as follows:to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock, to determine the change in PCT level over time as an aid in assessing the cumulative 28‑day risk of all-cause mortality for patients diagnosed with severe sepsis or septic shock in the ICU or when obtained in the emergency department or other medical wards prior to ICU admission,to aid in decision making on antibiotic therapy, for inpatients or patients in the emergency department with suspected or confirmed lower respiratory tract infections (LRTI) – defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of chronic obstructive pulmonary disease (AECOPD), to aid in decision making on antibiotic discontinuation for patients with suspected or confirmed sepsis. en 08828679500 Elecsys BRAHMS PCT en 5 FF00000006E2670E FF0000000476580E 08828679190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma.The Elecsys BRAHMS PCT assay can be used to aid in the early detection of clinically relevant bacterial infections.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en